Comparative genomic hybridization-based oncogenetic tree model for Genetic classification of breast cancer

Analytical and Quantitative Cytology and Histology

Volumn 31, Issue 2, 2009, Pages 101-108

  Friedrich, Katrin ^a   Von Heydebreck, Anja ^b   Haroske, Gunter ^c   Scheithauer, Jens ^a   Meyer, Wolfdietrich ^a   Kunze, Klaus Dietmar ^a   Baretton, Gustavo ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b MERCK KGAA   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Breast cancer; Chromosomal imbalances; Mathematical model; Oncogenetic tree model; Tumor progression

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAXIMUM LIKELIHOOD METHOD; MODEL; ONCOGENETIC TREE MODEL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASM STAGING; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 64549114088     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W: Comparative genomic hybridization of ductal carcinoma in situ of the breast: Evidence of multiple genetic pathways. J Pathol 1999;187:396-402
2. Isola J, Chu L, DeVries S, Matsumura K, Chew K, Ljung BM, Waldman FM: Genetic alterations in ERBB2-amplified breast carcinomas. Clin Cancer Res 1999;5:4140-4145
3. Jain AN, Chin K, B0rresen-Dale AL, Erikstein BK, Eynstein Lonning P, Kaaresen R, Gray JW: Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci U S A 2001;98:7952-7957
4. Loveday R, Greenman J, Drew PJ, Monson JR, Kerin MJ: Genetic changes associated with telomerase activity in breast cancer. Int J Cancer 1999;84:516-520
5. Roylance R, Gorman P, Hanby A, Tomlinson I: Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 2002;196:32-36
6. Schwendel A, Richard F, Langreck H, Kaufmann O, Lage H, Winzer KJ, Petersen I, Dietel M: Chromosome alterations in breast carcinomas: Frequent involvement of DNA losses including chromosome 4q and 21 q. Br J Cancer 1998;78:806- 811
7. Wessels LF, van Welsem T, Hart AA, van't Veer LJ, Reinders MJ, Nederlof PM: Molecular classification of breast carcinomas by comparative genomic hybridization: A specific somatic genetic profile for BRCA1 tumors. Cancer Res 2002;62: 7110-7117
8. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, B0rresen-Dale AL, Botstein D: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003;100: 8418-8423
9. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jaza- eri A, Martiat P, Fox SB, Harris AL, Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393-10398
10. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532
11. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997;57:1597-1604
12. Desper R, Jiang F, Kallioniemi OP, Moch H, Papadimitriou CH, Schäffer AA: Distance-based reconstruction of tree models for oncogenesis. J Comput Biol 2000;7:789-803
13. Heydebreck AV, Gunawan B, Füzesi L: Maximum likelihood estimation of oncogenetic tree models. Biostatistics 2004;5: 545-556
14. Jiang F, Desper R, Papadimitriou CH, Schäffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H: Construction of evolutionary tree model for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000;60:6503-6509
15. Moch H, Mihatsch MJ: Genetic progression of renal cell carcinoma. Virchows Arch 2002;441:320-327
16. Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey- Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K,
17. Kuukasjärvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egils- son V, Barkardottir RB, Johannsson O, Haraldsson K, Sand- berg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehma- nen P, Eerola H, Heikkila P, Pyrh5nen S, Nevanlinna H: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A 2000;97:9603-9608
18. Sobin LH, Wittekind C (editors): TNM Classification of Malignant Tumours. Sixth Edition. New York, Wiley-Liss, 2002
19. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-410
20. Friedrich K, Scheithauer J, Dimmer V, Meyer W, Theissig F, Haroske G, Kunze KD: DNA ploidy and chromosomal imbalances in invasive ductal breast cancer: A comparative study of DNA image cytometry and comparative genomic hybridization (CGH). Anal Cell Pathol 2000;20:69-82
21. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M: Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, lOq, 13q and 17p. Br J Cancer 1997;75:79-86
22. Roth K, Wolf G, Dietel M, Petersen I: Analysis program for quantitative detection of chromosome aberrations using comparative genomic hybridization. Pathologe 1996;17: 342-348 (in German)
23. Przybytkowski E, Girouard S, Allard B, Lamarre L, Basik M: Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalance. Cancer Res 2003;63:4588-4593
24. Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Bocker W: Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000;53:118-121
25. Höglund M, Gisselsson D, Hansen GB, Sail T, Mitelman F: Multivariate analysis if chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationship among imbalances. Cancer Res 2002;62:2675- 2680
26. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J: Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis: A study of 305 tumors by comparative genomic hybridization. Cancer Res 2003;63:8861-8868
27. Pandis N, Idvall I, Bardi G, Jin Y, Gorunova L, Mertens F, Olsson H, Ingvar C, Beroukas K, Mitelman F, Heim S: Correlation between karyotypic pattern and clinicopathologic features in 125 breast cancer. Int J Cancer 1996;66:191-196
28. Hansen LL, Yilmaz M, Overgaard J, Andersen J, Kruse TA: Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998;58: 2166-2169
29. Zudaire I, Odero MD, Caballero C, Valenti C, Martinez- Penuela JM, Isola J, Calasanz MJ: Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas. Histopatholo- gy 2002;40:547-555
30. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S: Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 1994;54:513-517
31. Cleton-Jansen AM, Buerger H, Haar N, Philippo K, van de Vijver MJ, Boecker W, Smit VT, Cornelisse CJ: Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004;41:109-116